Invesco’s Alto Neuroscience ANRO Stock Holding History

Invesco’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$376K	Buy	+14,255	New	+$330K	﹤0.01%	3356
2025 Q2	–	Sell	-31,031	Closed	-$67K	–	3896
2025 Q1	$67K	Buy	+31,031	New	+$111K	﹤0.01%	3675

Other funds holding ANRO

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Invesco's ANRO Position: Q2 2026 in Review

Invesco opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 14,255 shares worth $376K. The stake represents ﹤0.01% of the portfolio and ranks #3356 among its holdings. This is a return to the name: Invesco previously reported a position in ANRO as recently as Q1 2025.

Invesco first reported a position in ANRO in Q1 2025 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

Invesco held 14,255 shares of Alto Neuroscience worth $376K as of Q2 2026.
Alto Neuroscience was a new Invesco position in Q2 2026.
Alto Neuroscience made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3356 holding.
Invesco first reported a position in Alto Neuroscience in Q1 2025 and has held it in 2 quarters since.
114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.